British Columbia Investment Management’s NeoGenomics NEO Stock Holding History

British Columbia Investment Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-156,000	Closed	-$5.32M	–	845
2021 Q4	$5.32M	Hold	156,000	–	–	0.03%	429
2021 Q3	$7.53M	Hold	156,000	–	–	0.04%	333
2021 Q2	$7.05M	Hold	156,000	–	–	0.04%	354
2021 Q1	$7.52M	Sell	156,000 -97,900	-39%	-$5.1M	0.05%	289
2020 Q4	$13.7M	Sell	253,900 -58,000	-19%	-$2.62M	0.1%	187
2020 Q3	$11.5M	Sell	311,900 -51,300	-14%	-$1.91M	0.09%	184
2020 Q2	$11.3M	Buy	363,200 +149,600	+70%	+$4.15M	0.11%	167
2020 Q1	$5.9M	Buy	213,600 +116,200	+119%	+$3.48M	0.1%	182
2019 Q4	$2.85M	Buy	+97,400	New	+$2.32M	0.02%	558

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

British Columbia Investment Management's NEO Position: Q1 2022 in Review

British Columbia Investment Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 156,000 shares — an estimated $5.32M sold.

British Columbia Investment Management first reported a position in NEO in Q4 2019 and held it in 9 quarters. The position peaked at $13.7M in Q4 2020. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

British Columbia Investment Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
British Columbia Investment Management sold 156,000 NeoGenomics shares in Q1 2022, an estimated $5.32M.
British Columbia Investment Management first reported a position in NeoGenomics in Q4 2019 and held it in 9 quarters.
British Columbia Investment Management's NeoGenomics position peaked at $13.7M in Q4 2020.
280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on British Columbia Investment Management's 13F filing for Q1 2022, filed 12 May 2022.